Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Skin changes can signal diabetes and metabolic issues, aiding early diagnosis and treatment.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Human placenta extracts may help treat various diseases.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Living Skin Equivalent transplantation helps heal ischemic non-healing wounds.

People in Moldova have less selenium in their hair than recommended, which may contribute to hair loss.

Gut bacteria may affect hair loss in people with celiac disease.

Men with high testosterone may have higher morning blood pressure, unlike those with high DHT.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

The patient with Hoffman's folliculitis got better with the right treatment, leading to hair regrowth.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Barophoresis is a feasible and safe method for treating chronic generalized periodontitis.

Electrical and chemical skin stimulation can improve hair growth.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

Combining iron supplements with physiotherapy could better treat women's hair loss linked to iron deficiency.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Iron supplements and physiotherapy together can better treat hair loss in women with iron deficiency.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

PRP can help regrow hair and improve hair density in people with androgenetic alopecia.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Follicular microautotransplantation effectively improves scalp scars and enhances quality of life.

Growth factors influence hair growth and hair loss.

Phytochemicals in hair masks can help with damaged hair, seborrhea, and hair loss.

Patients with non-scarring hair loss often have emotional disorders.